The Reversible and Selective FGFR2-3 inhibitor CGT4859 has Superior Target Coverage of Resistance Mutations Missed by Leading FGFR Inhibitors

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

File size: 1.46 MB
Created: April 2025
Updated: April 2025
Hits: 29
Download Preview
Scroll to Top
Scroll to Top